Guillain-Barré Syndrome Linked to COVID-19 Shots
A study by the University College London showed that serious Guillain-Barré syndrome (GBS), which can result in temporary or permanent paralysis, is a “small but significant” risk associated with AstraZeneca/Oxford University’s AZD1222 (or “Vaxzevria”) vaccine. Of the 996 cases of GBS that were recorded in the United Kingdoms’ National Immunisation Management System database between January […]
There is No Autism Epidemic?
The prevalence of autism among children in the United States in the 1960s was estimated at 1 in 10,000. By the 1980s, prevalence of the neurological condition had increased to about 2 in 10,000 children. By the 1990s, the rate under the broader classification of autism spectrum disorder (ASD) was estimated at 1 in 2,500 […]
More Monkeypox Cases Identified as Roche is Ready With PCR Tests
There had been 584 confirmed cases of monkeypox virus in 26 countries as of May 31, 2022.1 The largest outbreak is in the United Kingdom where 190 people are infected with the virus, followed by Spain with 132 people infected, and Portugal with 100 people infected. Before this year, monkeypox in humans was thought to […]
Pfizer, Moderna Apply for EUA for COVID Shots for Infants, FDA to Decide Quickly
On June 1, 2022, Pfizer and BioNTech submitted an application to the U.S. Food and Drug Administration (FDA) for an Emergency Use Authorization (EUA) to distribute their messenger RNA (mRNA) BNT162b2 (also known as “Comirnaty”) COVID-19 biologic for children as young as six months to five years old. The application is for a three-dose regimen, […]
Doctor in India Sues Government Over COVID-19 Vaccine
Jacob Puliyel, MD, a pediatrician in India for more than 40 years, brought suit in the Supreme Court of India against the Union of India and COVID-19 vaccine manufacturers in a legal challenge to the country’s COVID vaccine program.1 Dr. Puliyel, who has served as Director of Research and Projects at Holy Family Hospital in Delhi […]
Paxlovid Users May Face Rebound SARS-CoV-2
The U.S. Centers for Disease Control and Prevention (CDC) has admitted that COVID-19 patients may experience a rebound SARS-CoV-2 infection after taking Pfizer’s antiviral drug, Paxlovid. Evidence has shown that patients, including those who have gotten COVID shots and been boosted, may suffer a reoccurrence of COVID two to eight days after completing a five-day […]